Matches in Wikidata for { <http://www.wikidata.org/entity/Q85035986> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q85035986 description "artículu científicu espublizáu en setiembre de 2011" @default.
- Q85035986 description "scientific article published on 30 September 2011" @default.
- Q85035986 description "wetenschappelijk artikel" @default.
- Q85035986 description "wissenschaftlicher Artikel" @default.
- Q85035986 description "наукова стаття, опублікована у вересні 2011" @default.
- Q85035986 name "Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors" @default.
- Q85035986 name "Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors" @default.
- Q85035986 type Item @default.
- Q85035986 label "Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors" @default.
- Q85035986 label "Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors" @default.
- Q85035986 prefLabel "Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors" @default.
- Q85035986 prefLabel "Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors" @default.
- Q85035986 P1433 Q85035986-BF9ABBBB-F328-4D16-A60B-29810938B1CC @default.
- Q85035986 P1476 Q85035986-CDC8A722-1483-4B8E-837E-97F3407D00AE @default.
- Q85035986 P2093 Q85035986-2F1EBA1F-A780-4386-832E-DD44D5797BD5 @default.
- Q85035986 P2093 Q85035986-311385A2-8AC4-45B3-8321-EF597D519FDE @default.
- Q85035986 P2093 Q85035986-6D9DC699-7D62-4E39-87D5-C8A68CE981CB @default.
- Q85035986 P2093 Q85035986-80FDAD8C-DF04-461B-A0B5-1AC1D525FA3D @default.
- Q85035986 P2093 Q85035986-D50D37F7-5F21-4DD6-8CE3-67DFD16796C3 @default.
- Q85035986 P304 Q85035986-38691DF0-EF8E-43A1-B4BF-5FF846D39D37 @default.
- Q85035986 P31 Q85035986-1D91EBAD-C41E-4AC5-9EB2-CC83B8ED6548 @default.
- Q85035986 P356 Q85035986-31C1AB26-1C5C-4CC3-B93C-FF28D13E05C8 @default.
- Q85035986 P433 Q85035986-991F9AD3-1674-4AC3-8426-31970144B3F8 @default.
- Q85035986 P478 Q85035986-CAEF62C1-82EC-44AF-BD8A-5244161FBEF1 @default.
- Q85035986 P50 Q85035986-54916043-DC24-4ACC-9B00-0458F740AF13 @default.
- Q85035986 P577 Q85035986-842C7346-2E2A-4A56-A56E-C2172B644DBB @default.
- Q85035986 P698 Q85035986-4824DB13-D47B-4A2D-88D4-3500D5ACD22A @default.
- Q85035986 P921 Q85035986-43FE2F35-A49E-472F-A414-AC8C7FAEF809 @default.
- Q85035986 P921 Q85035986-7FE81DBA-6369-4BA6-811B-5F3E40AF30C1 @default.
- Q85035986 P356 000331010 @default.
- Q85035986 P698 21968463 @default.
- Q85035986 P1433 Q2016300 @default.
- Q85035986 P1476 "Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors" @default.
- Q85035986 P2093 "Christopher Zergebel" @default.
- Q85035986 P2093 "Ellen Hollywood" @default.
- Q85035986 P2093 "Kaku Saito" @default.
- Q85035986 P2093 "Ki Y Chung" @default.
- Q85035986 P2093 "Michal Segal" @default.
- Q85035986 P304 "65-72" @default.
- Q85035986 P31 Q13442814 @default.
- Q85035986 P356 "10.1159/000331010" @default.
- Q85035986 P433 "2" @default.
- Q85035986 P478 "81" @default.
- Q85035986 P50 Q37830465 @default.
- Q85035986 P577 "2011-09-30T00:00:00Z" @default.
- Q85035986 P698 "21968463" @default.
- Q85035986 P921 Q413299 @default.
- Q85035986 P921 Q422327 @default.